title: [Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].
abstract: A 66-year-old man showed central nervous system (CNS) and epididymis involvement after concurrent chemoradiotherapy for extranodal natural killer/T-cell lymphoma, nasal type (ENKL). The patient experienced continuous nasal obstruction. CT revealed a mass in the nasal cavity and paranasal sinuses. Biopsy of the nasal cavity mass showed it to be ENKL. Based on bone marrow biopsy and 18F-FDG PET/CT findings, the clinical stage was suspected to be IIE. The sites involved were the nasal cavity, paranasal sinuses, and cervical lymph nodes. We performed concurrent chemoradiotherapy consisting of a 67% dose of DeVIC and involved field radiation therapy towards his head and neck. Head and neck CT confirmed a therapeutic response. After receiving concurrent chemoradiotherapy, the patient complained of perineal discomfort. Ultrasonography revealed swelling of the left epididymis. Left epididymis biopsy showed ENKL involvement and lumbar puncture revealed CNS involvement. The findings of this case suggest that evaluation of CNS involvement might be an essential part of the initial workup for some ENKL patients.
authors.affiliation: Department of Hematology, Kokura Memorial Hospital.
authors.forename: Yuya
authors.initials: Y
authors.lastname: Sasaki
authors.forename: Akihito
authors.initials: A
authors.lastname: Yonezawa
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kinoshita
authors.forename: Tomoya
authors.initials: T
authors.lastname: Kitagawa
authors.forename: Minako
authors.initials: M
authors.lastname: Mori
authors.forename: Takashi
authors.initials: T
authors.lastname: Onaka
authors.forename: Kazunori
authors.initials: K
authors.lastname: Imada
mesh_terms: D000368:Aged; D016543:Central Nervous System Neoplasms / Q000473:pathology* / Q000628:therapy; D059248:Chemoradiotherapy / Q000379:methods; D004822:Epididymis / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009361:Neoplasm Invasiveness; D009669:Nose Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology